Bavarian Nordic A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Bavarian Nordic issues FY 2014 revenue guidance in line with analysts' estimates
Bavarian Nordic A/S:Expects FY 2014 revenue to be at the level of 1,200 million Danish crowns / $222 million and a break-even result before interest and tax.FY 2014 revenue 1,157 million Danish crowns - Thomson Reuters I/B/E/S Estimates.
Latest Developments for Bavarian Nordic A/S
Latest Key Developments in Pharmaceuticals
- Skyepharma PLC gives H2 2014 revenue outlook
- Vectura Group plc announces first approval in Latin America for AirFluSal
- Zhangzhou Pientzehuang Pharmaceutical to sell stake in subsidiary
- Cellectar Biosciences, Inc announces closing of public offering and partial exercise of underwriter's over-allotment option
- Share this
- Digg this